These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3797771)

  • 1. [Liver cirrhosis and the renin-angiotensin-aldosterone system].
    Lozano de León F; Leal M; Lissen E
    Rev Esp Enferm Apar Dig; 1986 Nov; 70(5):465-8. PubMed ID: 3797771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 3. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of ascites in cirrhosis of liver. II.
    Liebowitz HR
    N Y State J Med; 1969 Jul; 69(14):2012-24. PubMed ID: 4894218
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the study of the interference of the renin-angiotensin-aldosterone system during the development of chronic alcoholic hepatopathy].
    Bourel M; Pirot D; Lenoir P; Chauvel A; Pawlotsky Y; Simon M
    Rev Int Hepatol; 1968; 18(7):871-94. PubMed ID: 4307168
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin angiotensin system and liver fibrosis or cirrhosis].
    Shen FJ; Yin CH; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):447-8. PubMed ID: 12890362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of changes in central hemodynamics and hormonal systems of its regulation on the etiology of portal hypertension complications in patients with liver cirrhosis].
    Tsykin DB; Iampol'skaia LI; Borisov AE; Tsykina GA; Shcherba IuV; Oktiabr'skaia IN; Levina AE
    Klin Med (Mosk); 1995; 73(4):99. PubMed ID: 7474848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 17. Deranged sodium homeostasis in cirrhosis.
    Epstein M
    Gastroenterology; 1979 Mar; 76(3):622-35. PubMed ID: 428715
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
    Martin PY; Ginès P; Schrier RW
    N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].
    Marmo R; Persico M; Costume A; Bronzino P; Del Vecchio E; Gentile S; Porcellini M
    Clin Ter; 1984 Dec; 111(5):443-9. PubMed ID: 6151436
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic derangement and cardiac dysfunction in cirrhosis.
    Gentilini P; La Villa G; Laffi G; Pinzani M
    Ann Ital Med Int; 2004; 19(2):90-7. PubMed ID: 15317269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.